Atlas Trials

Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

Clinical trial NCT06669754 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06669754
Sponsor
Pharvaris Netherlands B.V.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Hereditary Angioedema (HAE)
Start date
2024-12-01
Primary completion
2026-08-01
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.